Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Xuelu Wang

Novo Nordisk Postdoctoral Research Fellow

After graduating with a BSc in Life Science from the University of Science and Technology of China, I moved to the University of Cambridge for my PhD study under the supervision of Dr Marko Hyvönen. I studied the structure and function of pro-activin A, the precursor form of a key growth factor activin A and obtained my PhD degree in Biochemistry in 2016. I then worked as a Postdoctoral Research Associate in the Department of Biochemistry, University of Cambridge, continuing the research on activins and other Transforming Growth Factor beta (TGF-beta) superfamily members with the focus on protein engineering for stem cell and regenerative medicine applications. TGF-beta superfamily is widely involved in developmental processes and tissue homeostasis. With my Novo Nordisk Postdoctoral Research Fellowship I plan to pursue my research interests to further understand the roles of these growth factors in diabetes and other metabolic diseases.

I joined the labs of Professor Fredrik Karpe and Dr Costas Christodoulides in November 2019 to study the role of ACVR1C signalling in human fat distribution that has shown strong correlation to the development of many metabolic diseases.